Medical and surgical management of metastatic bowel cancer (mCRC) has improved over recent years, but treatments for mCRC patients that deliver even modest incremental life-extending benefits remain limited compared to those available for patients with other common cancers.

With just over one in ten (13.4%) mCRC patients surviving five years after diagnosis, there is a clear clinical need for new treatment options.  

Bowel Cancer Australia is pleased to have been selected as a charity beneficiary of the new Ritchies Community Benefit Program.

Donating a percentage of the money spent by registered customers to their nominated charity, including Bowel cancer Australia, the Ritchies Community Benefit Program now has an App for both IOS and Android smart devices. 

Ian Thatcher brings extensive professional experience as a global financial advisor to his role as a Director on the Bowel Cancer Research Foundation Australia Board.

A passionate believer in team-based pioneering to deliver breakthroughs, Ian found himself attracted to the charity’s commitment to leading-edge bowel cancer discoveries that have an everlasting impact on Australian health.

Play For Purpose is the ultimate not-for-profit raffle!
Every ticket gives you the chance to win awesome prizes, all while supporting Bowel Cancer Australia.
Raffle tickets are just $10, with a guaranteed minimum of $5 directly supporting the charity.

In recognition of World mCRC Day, Marty has joined Bowel Cancer Australia and our international partners to raise awareness about metastatic colorectal (bowel) cancer.

In mid-December 2019, I was diagnosed with Stage 4 metastatic bowel cancer, at age 42.

It took about 6 weeks to get myself into a frame of mind to deal with it.

Are you up for the challenge of trying a plant-based menu for seven days this Meat Free Week and raising funds for Bowel Cancer Australia, challenging participants to try a plant-based menu for seven days.

Zoe Welham developed an interest in bowel cancer while she was working on a complex scientific research project in graduate school.

“The goal was to look at bowel cancer in a holistic way by taking information from genes, microbes and epigenetic data,” Zoe said.

As co-founder and executive chairman of one of Australia’s largest consumer magazine publishing businesses, David Gardiner has turned unknown brands into household names.

But bowel cancer doesn’t discriminate, and despite his personal success, David was diagnosed with Australia’s second deadliest cancer at age 51.

Inspired by the commitment of patron Richard Penn to improving outcomes for people affected by bowel cancer, Gavin Fox-Smith joined Bowel Cancer Australia’s board in 2004.

“I’ve always believed in the mission,” said Gavin.